Beyond Air, Inc. Files 8-K: Board & Officer Changes
Ticker: XAIR · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1641631
| Field | Detail |
|---|---|
| Company | Beyond Air, Inc. (XAIR) |
| Form Type | 8-K |
| Filed Date | Nov 28, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, filing
Related Tickers: XAIR
TL;DR
Beyond Air (XAIR) filed an 8-K on 11/21/25 for board/officer changes & comp. Watch for updates.
AI Summary
On November 21, 2025, Beyond Air, Inc. filed an 8-K report detailing changes in its board of directors and executive officers, including the election of new directors and the appointment of certain officers. The filing also addresses compensatory arrangements for these officers and includes a Regulation FD disclosure. Additionally, it contains financial statements and exhibits.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty and signal potential strategic shifts, warranting closer monitoring by investors.
Key Players & Entities
- Beyond Air, Inc. (company) — Registrant
- November 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-38892 (commission_file_number) — SEC File Number
- 47-3812456 (ein) — I.R.S. Employer Identification No.
- AIT Therapeutics, Inc. (company) — Former Company Name
- 20170117 (date) — Date of Former Company Name Change
- KokiCare, Inc. (company) — Former Company Name
- 20150507 (date) — Date of Former Company Name Change
FAQ
What specific changes were made to Beyond Air, Inc.'s board of directors and executive officers?
The 8-K filing indicates the election of directors and the appointment of certain officers, along with details on their compensatory arrangements.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
The Regulation FD Disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What types of financial statements and exhibits are included with this 8-K filing?
The filing explicitly states that 'Financial Statements and Exhibits' are included, though specific details of these documents are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on November 21, 2025.
What were Beyond Air, Inc.'s previous names?
Beyond Air, Inc. was formerly known as AIT Therapeutics, Inc. (name change on 20170117) and KokiCare, Inc. (name change on 20150507).
Filing Stats: 607 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2025-11-28 13:05:53
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-025348.txt ( ) — 237KB
- xair-20251121.xsd (EX-101.SCH) — 3KB
- xair-20251121_lab.xml (EX-101.LAB) — 33KB
- xair-20251121_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEYOND AIR, Inc. Date: November 28, 2025 By: /s/ Steven A. Lisi Name: Steven A. Lisi Title Chief Executive Officer